Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 21855847)

1.

Knockdown of MADD and c-FLIP overcomes resistance to TRAIL-induced apoptosis in ovarian cancer cells.

Li LC, Jayaram S, Ganesh L, Qian L, Rotmensch J, Maker AV, Prabhakar BS.

Am J Obstet Gynecol. 2011 Oct;205(4):362.e12-25. doi: 10.1016/j.ajog.2011.05.035. Epub 2011 May 27.

2.

The overriding of TRAIL resistance by the histone deacetylase inhibitor MS-275 involves c-myc up-regulation in cutaneous, uveal, and mucosal melanoma.

Venza M, Visalli M, Oteri R, Agliano F, Morabito S, Teti D, Venza I.

Int Immunopharmacol. 2015 Jun 26;28(1):313-321. doi: 10.1016/j.intimp.2015.06.024. [Epub ahead of print]

PMID:
26122536
3.

TRAIL suppresses human breast cancer cell migration via MADD/CXCR7.

Wang R, Li JC.

Asian Pac J Cancer Prev. 2015;16(7):2751-6.

4.

PCTAIRE1-knockdown sensitizes cancer cells to TNF family cytokines.

Yanagi T, Shi R, Aza-Blanc P, Reed JC, Matsuzawa S.

PLoS One. 2015 Mar 19;10(3):e0119404. doi: 10.1371/journal.pone.0119404. eCollection 2015.

5.

Mechanisms of action of 17βH-neriifolin on its anticancer effect in SKOV-3 ovarian cancer cell line.

Mutalip SS, Yunos NM, Abdul-Rahman PS, Jauri MH, Osman A, Adenan MI.

Anticancer Res. 2014 Aug;34(8):4141-51.

PMID:
25075041
6.

MADD knock-down enhances doxorubicin and TRAIL induced apoptosis in breast cancer cells.

Turner A, Li LC, Pilli T, Qian L, Wiley EL, Setty S, Christov K, Ganesh L, Maker AV, Li P, Kanteti P, Das Gupta TK, Prabhakar BS.

PLoS One. 2013;8(2):e56817. doi: 10.1371/journal.pone.0056817. Epub 2013 Feb 15.

7.

MADD promotes the survival of human lung adenocarcinoma cells by inhibiting apoptosis.

Bi W, Wei Y, Wu J, Sun G, Guo Y, Zhang Q, Dong L.

Oncol Rep. 2013 Apr;29(4):1533-9. doi: 10.3892/or.2013.2258. Epub 2013 Jan 29.

PMID:
23443411
8.

mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis.

Zhao L, Yue P, Khuri FR, Sun SY.

Cancer Res. 2013 Mar 15;73(6):1946-57. doi: 10.1158/0008-5472.CAN-12-3710. Epub 2013 Jan 14.

9.

c-FLIP, a master anti-apoptotic regulator.

Safa AR.

Exp Oncol. 2012 Oct;34(3):176-84. Review.

PMID:
23070002
11.

Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions.

Zhuang H, Jiang W, Zhang X, Qiu F, Gan Z, Cheng W, Zhang J, Guan S, Tang B, Huang Q, Wu X, Huang X, Jiang W, Hu Q, Lu M, Hua ZC.

J Mol Med (Berl). 2013 Feb;91(2):219-35. doi: 10.1007/s00109-012-0947-3. Epub 2012 Sep 5.

PMID:
22948392
12.

Control of FLIP(L) expression and TRAIL resistance by the extracellular signal-regulated kinase1/2 pathway in breast epithelial cells.

Yerbes R, López-Rivas A, Reginato MJ, Palacios C.

Cell Death Differ. 2012 Dec;19(12):1908-16. doi: 10.1038/cdd.2012.78. Epub 2012 Jun 22.

13.
14.

Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas.

Giaisi M, Köhler R, Fulda S, Krammer PH, Li-Weber M.

Int J Cancer. 2012 Aug 15;131(4):1003-8. doi: 10.1002/ijc.26458. Epub 2011 Nov 8.

PMID:
21952919
15.

Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas.

Lefave CV, Squatrito M, Vorlova S, Rocco GL, Brennan CW, Holland EC, Pan YX, Cartegni L.

EMBO J. 2011 Sep 13;30(19):4084-97. doi: 10.1038/emboj.2011.259.

16.

The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cells.

Zhao L, Yue P, Lonial S, Khuri FR, Sun SY.

Mol Cancer Ther. 2011 Dec;10(12):2415-25. doi: 10.1158/1535-7163.MCT-11-0401. Epub 2011 Sep 13.

18.

KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels.

Llobet D, Eritja N, Domingo M, Bergada L, Mirantes C, Santacana M, Pallares J, Macià A, Yeramian A, Encinas M, Moreno-Bueno G, Palacios J, Lewis RE, Matias-Guiu X, Dolcet X.

Am J Pathol. 2011 Apr;178(4):1529-43. doi: 10.1016/j.ajpath.2010.12.041.

19.

Chemotherapy overcomes TRAIL-R4-mediated TRAIL resistance at the DISC level.

Morizot A, Mérino D, Lalaoui N, Jacquemin G, Granci V, Iessi E, Lanneau D, Bouyer F, Solary E, Chauffert B, Saas P, Garrido C, Micheau O.

Cell Death Differ. 2011 Apr;18(4):700-11. doi: 10.1038/cdd.2010.144. Epub 2010 Nov 12.

20.

α-TEA induces apoptosis of human breast cancer cells via activation of TRAIL/DR5 death receptor pathway.

Yu W, Tiwary R, Li J, Park SK, Jia L, Xiong A, Simmons-Menchaca M, Sanders BG, Kline K.

Mol Carcinog. 2010 Nov;49(11):964-73. doi: 10.1002/mc.20681.

PMID:
20886583
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk